Chandigarh Nov.06, 2021:- Male and female pattern hair loss, also known as androgenic alopecia, continues to remain a prominent area of concern, especially in the age groups of 25 and onwards. Clinicians and cosmetologists have been investigating modalities for a long time now. While nonsurgical hair regrowth treatments like over-the-counter topical minoxidil, prescription oral finasteride, platelet-rich plasma (PRP) injections and light & laser therapy treatments help reduce hair fall when used in combination, they do leave adverse side effects. Meet QR678® – a proprietary, first in class hair fall & hair regrowth therapy, which has revolutionized the treatment of hair fall in alopecia. This formulation has been named QR678 inspired by the new generation ubiquitous presence of “Quick Response” QR code. 678 in Morse code signifies “there is no answer.
The therapy was invented by Dr. Debraj Shome – Clinical Scientist & Leader, R&D Team, QR678®and Dr.Rinky Kapoor; Both are celebrity cosmetic surgeons from India and co -founders of The Esthetic Clinics ® which are a chain of top class dermatology & plastic surgery centers located in various cities in India. They observed that male pattern baldness, known as Androgenic Alopecia characterised by progressive hair loss in men growing at a rampant rate of 58% in males aged 30-50 years which initiated their urge to research and find a solution to this cosmetic issue leading to the invention of QR 678®. The therapy curbs hair fall and increases the thickness, the number and density of existing hair follicles, offering greater hair coverage to the ones with alopecia. They ran comparative trials between the QR 678® and PRP treatments with QR 678®treatment causing almost 300% better results than the PRP. The therapy also increases the uptake of traditional hair transplant by 50 %.
The hair-regrowth treatments available in the market currently have many limitations; they cannot revive hair beyond a certain stage. QR678® is a process where growth factors are injected in the hair follicles, which not only arrests hair fall but also stimulates hair growth. QR678® is a non-surgical, pain-free and non-invasive procedure for the hair regrowth treatment which has shown very good results in over 21,000+ patients. The QR678 therapy has been awarded the prestigious composition and mechanism of administration patent from the United States of America in 2017 and the Indian FDA gave an approval for commercial manufacturing & sale in March 2019. The therapy is also FDA approved in EU, UK, Kuwait and pending approvals in other countries. The Food & Drug Administration (FDA) approval means its effectiveness and efficacy has been reviewed by the CDER and it has been established that its benefits outweigh its potential risks.
In the EU and UK markets, the QR678® therapy launch has been initiated, after which the majority of the hair clinics in these markets will have access to the therapy. At present, the product is made at the QR678® facilities which are located in Korea; manufacturing units are being set up in Europe as we speak and there is a European entity which deals in distribution all around the world
Soon, QR678® would be filing a fresh patent globally, as the product is undergoing overhauling; The patent would be even more efficacious. The team is also coming up with their own level of hair care products including nutraceuticals, shampoos, serums and the likes.
Growth factors, hormonal imbalance, lifestyle choices, stress are all leading causes for hair loss; QR 678® bridges the gap as a proven solution.
There is a sharp rise in the number of temporary reversible hair loss cases in post-Covid patients due to physical and emotional stress. Hair loss post covid usually begins two or three months after the patient has recovered from Covid-19. Noticeable hair loss usually starts after an average of about 55 days post-recovery. Hair loss happens due to fever because of infection, diet changes, stress due to isolation and stress related factors. This hair loss is known as telogen effluvium. This condition is a temporary form of hair loss and is often seen in Covid patients because of the shock that the body sustains resulting from fever and other symptoms. Problems such as hair loss are fast emerging as one of the common side-effects of this pandemic; With just 4 sessions of the QR678®therapy, there is an increase in the density of existing hair follicles, offering great coverage to the ones with hair loss. This research study has also been published in the Journal of Cosmetic Dermatology.
Signals passed between the upper and lower layers of skin trigger the growth of hair follicles; The 3 stages of hair follicle development are anagen (growth), catagen (dormancy) and telogen (shedding); Extending the anagen phase helps in hair development and growth factors pass the signal to do just that. Growth factors tell the dermal papilla cells to start growing or trigger the anagen phase& QR 678 is a special preparation of those growth factors that send this message across with precision.
This process is facilitated by Mesotherapy which is carried out with the patented QR 678 molecules. These molecules are branded development elements, used by little practically pain-free administration into the scalp. Growth of hair calls for 5-8 sessions dispersed 2-3 weeks aside each. Typically 1 ml of solution is inserted per sitting, each sitting requires 15 mins, no medical center stay is needed, and every session costs approximately Rs. 7000.
This form of hair treatment/therapy is a mixture of natural growth factors that are already present in the scalp and therefore it is completely safe to use on everybody. It has the right concentration of specific hair growth factors, does not have any side effects, is performed as an outpatient procedure and the results are visible within eight weeks of starting the treatment. The therapy curbs hair fall and increases the thickness, the number and density of existing hair follicles, offering greater hair coverage to the ones with alopecia or male pattern baldness & female pattern hair loss. The QR 678 ® therapy has also demonstrated encouraging results in post chemotherapy induced hair loss, treatment of hair conditions like seborrheic dermatitis & in immunogenic diseases like alopecia areata.
While hairfall may look like a cosmetic issue, it tends to be a damaging mental issue. Our studies shows that hair fall does lead to psychological impact affecting personal relationships, confidence, growth prospects, making one look low on energy and vitality. In fact the Government of India perceives hair growth as a consumer line item i.e. GST is charged as the Government believes that hair regrowth is for cosmetic purposes only, however the QR678® studies show it is a medical issue leading to psychological factors.
A true ‘Made in India’ product that has gained an international reputation in producing most effective, efficient results faster than any other surgical and non-surgical hair regrowth treatment known today. The therapy is utilized in top skin and hair clinics with key opinion leaders in 10+ countries. Even though now the QR 678 ® hair growth therapy will be available through a chain of franchisees and distributors, The Esthetic Clinics® team remains the inventor and research and development team for the therapy. In the north markets specifically at the Punjab, the therapy has cured more than 2000 + patients. Especially in Punjab, COVID related hair fall has been severe and patients have really benefited with the QR678®. The cost of the QR678® is about the same as a traditional hair transplant and it is suitable for all age groups and genders.
Article Source – http://121newsonlines.blogspot.com/2021/11/qr-678r-new-age-solution-to-hair-loss.html